Shanghai OPM Biosciences Co. Ltd. A
医疗健康 · 生物科技
Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics. The company was founded in 2013 and is headquartered in Shanghai, China.
MARKET 市值 6.88B CNY PE 156.1x
52W ¥33.97 – ¥67.49
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 117.7%
▲ ROE 2.6% 营业利润率 4.4% 净利润率 14.6%
ANALYST 股息率 1.00%